Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Stone

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Psychopharmacology|December 2, 2019
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophreniaGrant McQueen, Aderlee Lay, John Lally, et al.
JAMA Psychiatry|November 15, 2018
Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for PsychosisMatthijs G Bossong, Mathilde Antoniades, Matilda Azis, et al.
Optics Express|April 29, 2009
Broadband tunable optical parametric amplification from a single 50 MHz ultrafast fiber laserYan-Wei Tzeng, Yen-Yin Lin, Chen-Han Huang, et al.
Chemical Communications (Cambridge, England)|January 16, 2016
Ion flow in a zeolitic imidazolate framework results in ionic diode phenomenaElena Madrid, Mark A Buckingham, James M Stone, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2021
GABA<sub>A</sub> and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophreniaAmanda Kiemes, Felipe V Gomes, Diana Cash, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2010
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptomsPaul D Morrison, Judith Nottage, James M Stone, et al.
Translational Psychiatry|May 30, 2023
The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatmentSameer Jauhar, Robert A McCutcheon, Mattia Veronese, et al.
Journal of Psychopharmacology (Oxford, England)|October 9, 2012
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairmentAmir Englund, Paul D Morrison, Judith Nottage, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2019
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging studyOliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, et al.
Biological Psychiatry Global Open Science|September 8, 2025
A Multimodal Observational Case-Control Study Exploring Gut Microbiota-Hippocampus Alterations in Individuals With High Positive Schizotypy From the General PopulationGalya C Iseli, Jorge F Vázquez-Castellanos, David Coynel, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Psychopharmacology|December 2, 2019
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophreniaGrant McQueen, Aderlee Lay, John Lally, et al.
JAMA Psychiatry|November 15, 2018
Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for PsychosisMatthijs G Bossong, Mathilde Antoniades, Matilda Azis, et al.
Optics Express|April 29, 2009
Broadband tunable optical parametric amplification from a single 50 MHz ultrafast fiber laserYan-Wei Tzeng, Yen-Yin Lin, Chen-Han Huang, et al.
Chemical Communications (Cambridge, England)|January 16, 2016
Ion flow in a zeolitic imidazolate framework results in ionic diode phenomenaElena Madrid, Mark A Buckingham, James M Stone, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2021
GABA<sub>A</sub> and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophreniaAmanda Kiemes, Felipe V Gomes, Diana Cash, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2010
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptomsPaul D Morrison, Judith Nottage, James M Stone, et al.
Translational Psychiatry|May 30, 2023
The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatmentSameer Jauhar, Robert A McCutcheon, Mattia Veronese, et al.
Journal of Psychopharmacology (Oxford, England)|October 9, 2012
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairmentAmir Englund, Paul D Morrison, Judith Nottage, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2019
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging studyOliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, et al.
Biological Psychiatry Global Open Science|September 8, 2025
A Multimodal Observational Case-Control Study Exploring Gut Microbiota-Hippocampus Alterations in Individuals With High Positive Schizotypy From the General PopulationGalya C Iseli, Jorge F Vázquez-Castellanos, David Coynel, et al.
Pageof 13